| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 09/02/2010 | US20100221191 Contrast agents |
| 09/02/2010 | US20100218414 Amphiphilic oxalamide organogelators designed for gelation of organic solvents, water and hydrocarbon commercial fuels |
| 09/01/2010 | EP1285651B1 Melanin concentrating hormone antagonists |
| 09/01/2010 | CN101821231A Contrast agents |
| 09/01/2010 | CN101820924A Contrast agents |
| 09/01/2010 | CN101820923A Contrast agents |
| 09/01/2010 | CN101820922A Contrast agents |
| 09/01/2010 | CN101817762A Preparation method of L-glutamine nitrate |
| 08/31/2010 | US7786328 e.g. benzoic acid 2-[4-dimethylamino-4-(3-methyl-benzyl)-cyclohexylcarbamoyl]-benzyl ester; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases |
| 08/31/2010 | US7786307 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders |
| 08/31/2010 | US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example |
| 08/31/2010 | US7786099 such as A-ring aromatized Minocycline, having antibacterial activity; antibiotics |
| 08/31/2010 | US7786098 (Z)-1-(3,4,5-trimethoxyphenyl)-2-(3'-amino-4'-trifluoroethoxyphenyl)-ethene, used to inhibit the polymerization of microtubules and for the treatment of tumor and neovascularization; anticarcinogenic agents |
| 08/31/2010 | US7786046 Benzoyl-substituted serineamides |
| 08/26/2010 | WO2010094659A1 Amine or amino alcohols as glyt1 inhibitors |
| 08/26/2010 | US20100215710 Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing |
| 08/26/2010 | US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm |
| 08/25/2010 | EP2220033A1 Crystalline forms of tigecycline hydrochloride |
| 08/25/2010 | EP2220032A1 Novel solvate |
| 08/25/2010 | EP2220031A1 Polymorphic forms of aliskiren hemifumarate and process for preparation thereof |
| 08/25/2010 | EP2220026A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase |
| 08/25/2010 | CN101811980A Methods for synthesizing substituted tetracycline compounds |
| 08/25/2010 | CN101811979A Technology for producing injection-grade terramycin |
| 08/25/2010 | CN101811978A Preparation method of 2-aminobutanamide hydrochloride |
| 08/25/2010 | CN101121676B Water gelling agent used for forming supermolecule hydrogel and preparation method thereof |
| 08/25/2010 | CN101041626B Tetrafluorobenzyl derivatives and pharmaceutical composition containing same |
| 08/24/2010 | US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 08/24/2010 | US7781470 Aminodicarboxylic acid derivatives having pharmaceutical properties |
| 08/24/2010 | US7780952 Distinguish between tumor cells and normal cells using novel contrast agents that contain a Magnetic Resonance Imaging (MRI) detectable moiety bound, optionally through a spacer, to a (pseudo)nutrient such as glucose, a natural or unnatural amino acid such as agmatine, or a polyamine such as spermidine |
| 08/24/2010 | CA2621323C Histamine-3 receptor antagonists |
| 08/19/2010 | WO2010092546A1 Androgen receptor modulating compounds, preparation and uses thereof |
| 08/19/2010 | WO2010091543A1 Novel hydrazino-cyclobut-3-ene-1, 2-dione derivatives as cxcr2 antagonists |
| 08/19/2010 | WO2010060041A3 Phenylalanine amide inhibitors of atp-sensitive potassium channels |
| 08/19/2010 | WO2010053329A3 Novel oligopeptide-derived cationic lipid, method for preparing same, and delivery system comprising same |
| 08/19/2010 | US20100210631 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators |
| 08/19/2010 | US20100209356 Contrast agents |
| 08/18/2010 | CN101805269A Method for separating and extracting natural theanine |
| 08/17/2010 | US7776924 for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy in conjunction with nitroreductase enzymes as hypoxia selective cytotoxins and as anticarcinogenic agents; 2((2-Bromoethyl)-2-{[(2-hydroxyethyl)amino]carbonyl}-4,6-dinitroanilino)ethyl methanesulfonate |
| 08/17/2010 | US7776922 Substituted [(phenylethanoyl)amino]benzamides |
| 08/17/2010 | US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis |
| 08/17/2010 | US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
| 08/17/2010 | US7776558 Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders |
| 08/17/2010 | CA2370412C Pharmaceutical compounds |
| 08/12/2010 | WO2010091277A2 Solid state forms of aliskiren compounds |
| 08/12/2010 | WO2010090282A1 3-aminoxalylaminobenzamide derivatives, and insecticidal and miticidal agents containing same as active ingredient |
| 08/12/2010 | WO2010090031A1 Method for producing optically active succinimide derivative and intermediate thereof |
| 08/12/2010 | WO2010089881A1 3-aminooxalylaminobenzamide derivative and pesticide/miticide containing the derivative as active ingredient |
| 08/12/2010 | US20100204504 Novel processes and compounds |
| 08/12/2010 | US20100204186 Aromatic a-ring derivatives of tetracycline compounds |
| 08/12/2010 | CA2724152A1 Solid state forms of aliskiren compounds |
| 08/11/2010 | EP2216323A2 Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| 08/11/2010 | EP2216322A1 Retinoid prodrug compound |
| 08/11/2010 | CN101801974A Process for the manufacture of bridged monobactam intermediates |
| 08/11/2010 | CN101801923A Pleuromutilin derivatives and their use as antimicrobials |
| 08/11/2010 | CN101798355A Method for integrated separation and extraction of tea polysaccharide, theanine, polyphenol and caffeine |
| 08/10/2010 | US7772432 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 08/10/2010 | US7772413 Amide and peptide derivatives of tetraalkylenepentamines as transfection agents |
| 08/10/2010 | CA2451768C Peptoid compounds |
| 08/10/2010 | CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 08/05/2010 | WO2010086394A1 Method for synthesis of (1s, 2r)-milnacipran |
| 08/05/2010 | US20100197962 Use of Neboglamine in the Treatment of Toxicodependency |
| 08/05/2010 | US20100197793 Solid state forms of aliskiren compounds |
| 08/05/2010 | US20100197753 Benzamides Useful as S1P Receptor Modulators |
| 08/05/2010 | US20100197736 Cetp activity inhibitors |
| 08/05/2010 | US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer |
| 08/05/2010 | US20100196502 Isoform Selective HDAC Inhibitors |
| 08/05/2010 | CA2750488A1 Method for synthesis of (1s, 2r)-milnacipran |
| 08/04/2010 | EP2213655A1 Methods For Purifying Aminoalkyl Tetracycline Compounds |
| 08/04/2010 | EP2212279A1 Cationic lipids |
| 08/04/2010 | CN101796016A Novel processes and compounds |
| 08/03/2010 | US7767831 purified polylactic acid or glycolic acid-lactic acid copolymer; insert for drugs |
| 08/03/2010 | US7767649 Gamma aminobutyric acid antagonist; naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative disorders; analgesics; drug withdrawal |
| 07/29/2010 | WO2010084772A1 Catalyst for stereoselective asymmetric nitroaldol reaction |
| 07/29/2010 | WO2010060941A3 Contrast agents |
| 07/29/2010 | WO2009153457A3 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action |
| 07/29/2010 | US20100190756 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 07/29/2010 | US20100190688 Tetrapeptide analogs |
| 07/29/2010 | CA2749981A1 Process for isolating tigecycline and tigecycline made therefrom |
| 07/28/2010 | CN101786991A Substituted tetracycline compounds |
| 07/28/2010 | CN101786971A Preparation process of doxycycline hydrochloride |
| 07/28/2010 | CN101130504B Synthesis, split and racemization method for preparing chirality medicament levetiracetam midbody (S)-(+)-2-amido butyramide hydrochlorate |
| 07/27/2010 | US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis |
| 07/27/2010 | CA2518435C Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation |
| 07/22/2010 | WO2010048332A3 Compounds for treating ophthalmic diseases and disorders |
| 07/22/2010 | WO2008155405A9 Crystalline solid forms |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/21/2010 | CN1826310B Novel aminobenzophenone compounds |
| 07/21/2010 | CN101784517A methods for synthesizing substituted tetracycline compounds |
| 07/21/2010 | CN101784516A Dipeptide analogs as coagulation factor inhibitors |
| 07/21/2010 | CN101781035A Method for recovering terramycin from terramycin production wastewater. |
| 07/21/2010 | CN101780381A N-alkylasparagine surfactant and preparation method thereof |
| 07/21/2010 | CN101195587B Production method for lodixanol hydrolysate |
| 07/21/2010 | CN101058548B Method for preparing theanine |
| 07/20/2010 | US7759519 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents |
| 07/20/2010 | US7759514 peptidomimetics such as (Z)-8-Amino-2-benzyl-3,7-dihydroxy-9-(4-hydroxy-phenyl)-non-4-enoic acid (1-carbamoyl-2-phenyl-ethyl)-amide, having improved selectivity to targets, improved bioavailability and lessened adverse side effects, used as analgesics |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/15/2010 | WO2010051935A3 Substituted amido phenoxybenzamides |
| 07/15/2010 | US20100179326 Benzamide derivative |
| 07/15/2010 | US20100178699 Multi-chain lipophilic polyamines |
| 07/15/2010 | US20100178324 Composition and method for the treatment of diseases affected by apoptosis |